SBM Share Price

Open 0.14 Change Price %
High 0.14 1 Day 0.00 0.00
Low 0.14 1 Week 0.00 0.00
Close 0.14 1 Month 0.00 0.00
Volume 5000 1 Year -0.04 -22.22
52 Week High 0.19
52 Week Low 0.12
SBM Important Levels
Resistance 2 0.14
Resistance 1 0.14
Pivot 0.14
Support 1 0.14
Support 2 0.14
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PUM 0.11 37.50%
PUM 0.11 37.50%
GLK 0.06 50.00%
GLK 0.06 50.00%
COD 0.07 0.00%
COD 0.07 0.00%
More..
CVE Canada Top Gainers Stocks
SHL 0.02 100.00%
SHL 0.02 100.00%
SHL 0.02 100.00%
TYE 0.02 100.00%
ELN 0.04 100.00%
ELN 0.04 100.00%
ELN 0.04 100.00%
ELN 0.04 100.00%
BXR 0.02 100.00%
CAP 0.02 100.00%
More..
CVE Canada Top Losers Stocks
KLM 0.01 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
GNT 0.13 -35.00%
More..

Sirona Biochem Corp (CVE: SBM)

SBM Technical Analysis 5
As on 31st Oct 2017 SBM Share Price closed @ 0.14 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.16 & Strong Sell for SHORT-TERM with Stoploss of 0.14 we also expect STOCK to react on Following IMPORTANT LEVELS.
SBM Target for November
1st Target up-side 0.15
2nd Target up-side 0.15
3rd Target up-side 0.15
1st Target down-side 0.13
2nd Target down-side 0.13
3rd Target down-side 0.13
SBM Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.sironabiochem.com
SBM Address
SBM
605-889 West Pender Street
Vancouver, BC V6C 3B2
Canada
Phone: 604-641-4466
Fax: 604-608-5471
SBM Latest News
Interactive Technical Analysis Chart Sirona Biochem Corp ( SBM CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sirona Biochem Corp
SBM Business Profile
Sirona Biochem Corp. operates as a cosmetic ingredient and drug discovery company in Canada. The company develops programs in three areas, including diabetes and cancer therapeutics; anti-aging and depigmenting agent in cosmeceuticals; biological ingredients, such as inducers and adjuvants for biological development. It develops a sodium glucose co-transporter inhibitor for the treatment of Type 2 diabetes; and a cancer vaccine antigen. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.